PROTEIOS TECHNOLOGY, INC. - SBIR PHASE II, TOPIC 429: A NEW PARADIGM FOR AUTOLOGOUS AND ALLOGENEIC CELL THERAPY MANUFACTURING

On Dec 11, 2025, Department of Health and Human Services obligated $2,049,979 to PROTEIOS TECHNOLOGY, INC. for sbir phase ii, topic 429: a new paradigm for autologous and allogeneic cell therapy manufacturing. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: full and open competition after exclusion of sources with 2 offers received. The procurement used a SMALL BUSINESS SET ASIDE - TOTAL set-aside. Performance is located in ISSAQUAH, WA. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.